Proteon Therapeutics (NASDAQ:PRTO) Insider James E. Flynn bought 691,713 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were purchased at an average price of $10.00 per share, for a total transaction of $6,917,130.00. Proteon Therapeutics, Inc. (NASDAQ:PRTO) belongs to Healthcare sector. Its weekly performance is 2.30%. On last trading day company shares ended up $10.24. Proteon Therapeutics, Inc. (NASDAQ:PRTO) distance from 50-day simple moving average (SMA50) is 1.90%.

Pandora Media (NYSE:P) Director Robert M. Kavner sold 10,000 shares of the stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $18.84, for a total value of $188,400.00. Following the transaction, the director now directly owns 20,669 shares in the company, valued at approximately $389,404. Pandora Media Inc (NYSE:P) shares decreased -3.55% in last trading session and ended the day at $18.18. P Gross Margin is 43.40% and its return on assets is -4.60%. Pandora Media Inc (NYSE:P) quarterly performance is -28.23%.

KCAP Financial, Inc. (Nasdaq:KCAP) will release its financial results for third quarter ended September 30, 2014 on Wednesday, November 5, 2014. The company will host a conference call on the same day at 4:00pm Eastern. On 05 November, KCAP Financial, Inc. (NASDAQ:KCAP) shares advanced 1.72% and was closed at $7.67. KCAP EPS growth in last 5 year was 16.80%. KCAP Financial, Inc. (NASDAQ:KCAP) year to date (YTD) performance is 0.79%.

Tarena International Inc (ADR) (NASDAQ:TEDU) is scheduled to announce its earnings results on Thursday, November 6th. Tarena International, Inc. (NASDAQ:TEDU) ended the last trading day at $12.87. Company weekly volatility is calculated as 6.02% and price to cash ratio as 4.60. Tarena International, Inc. (NASDAQ:TEDU) showed a weekly performance of 4.21%.

Emcore Corporation (NASDAQ:EMKR), a provider of compound semiconductor-based components, subsystems and systems for the fibre optics and space solar power industries, announced it has entered a definitive purchase agreement with NeoPhotonics, under which NeoPhotonics has agreed to purchase Emcore’s tunable laser and transceiver product lines for $17.5 million US, consisting of $1.5 million in cash at closing and a $16 million promissory note from NeoPhotonics. EMCORE Corporation (NASDAQ:EMKR) shares decreased -0.77% in last trading session and ended the day at $5.16. EMKR Gross Margin is 18.20% and its return on assets is -7.80%. EMCORE Corporation (NASDAQ:EMKR) quarterly performance is 28.36%.